Bk Virus Nephropathy
📧 Sign up to get email alerts when something new happens for Bk Virus Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Prediction of BK Virus Reactivation in Kidney Transplant Recipient [NA]
A completed clinical trial evaluating predictors of BK virus reactivation in kidney transplant recipients; the snippet does not provide resu…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia. [Phase 4]
Phase 4 multicenter randomized two-arm trial evaluating BK viral clearance in kidney transplant recipients with BK viremia has completed; th…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation. [Phase 4]
Phase 4 trial evaluating whether intravenous immunoglobulins can prevent BK virus infection in kidney transplant recipients, stratified by B…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation [Phase 2]
Phase 2 study to assess safety and tolerability of brincidofovir in kidney transplant recipients with BK virus infection (viremia); the tria…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia [Phase 2]
Phase 2 study of Posoleucel (formerly ALVR105; Viralym-M) in kidney transplant patients with BK viremia has completed, with results posted i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients [Phase 4]
Phase 4 open study evaluating whether early Mizoribine conversion prevents BK virus nephropathy in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Using mTOR Inhibitors in the Prevention of BK Nephropathy [NA]
A completed clinical trial evaluated the use of mTOR inhibitors to prevent BK virus nephropathy and BK virus viremia in transplant recipient…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy [Phase 4]
A Phase 4 trial update examining how different immunosuppressive regimens influence BK virus nephropathy in transplant recipients; the study…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation
Clinical trial comparing cyclosporine versus tacrolimus after Campath induction in kidney transplantation is completed. Results were posted …
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Cidofovir in Renal Transplant Recipients With BKVN [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated cidofovir for BK virus nephropathy in kidney transplant recipients; the study was terminated and result…